title: [News in the treatment of patients with hemophilia. Virus-inactivated coagulation factor concentrates, artificial joints and prenatal diagnosis].
abstract: The article cites examples of recent progress in the treatment of hemophilia in Norway. Virus-inactivated coagulation factor-concentrates prepared from Norwegian plasma have been introduced. We present the results of orthopedic surgery in hemophilic patients and progress in prenatal diagnosis of hemophilia.
authors.forename: P
authors.initials: P
authors.lastname: Stavem
authors.forename: S A
authors.initials: SA
authors.lastname: Evensen
authors.forename: B
authors.initials: B
authors.lastname: Solheim
authors.forename: J C
authors.initials: JC
authors.lastname: Teigland
mesh_terms: D001779:Blood Coagulation Factors / Q000008:administration & dosage; D005260:Female; D006467:Hemophilia A / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D007595:Joint Prosthesis; D011247:Pregnancy; D011296:Prenatal Diagnosis
chemical_list: D001779:Blood Coagulation Factors
vernacular_title: Nytt i behandlingen av blødersykdom. Virusinaktiverte koagulasjonsfaktorkonsentrater, kunstige ledd og prenatal diagnostikk.